Abeona Therapeutics Inc (ABEO) Stock Price

5.12 ▼ -0.08 (-1.54%)
Open: 5.115 Vol: 12.21K Day's range: 5.065 - 5.17 Feb 27, 15:59 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ABEO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 5.11▲ 5.12▼ 5.12▼ 5.24▼ 5.12▼
MA10 5.13▼ 5.13▼ 5.14▼ 5.19▼ 5.20▼
MA20 5.12▼ 5.13▼ 5.18▼ 5.14▼ 5.06▲
MA50 5.13▼ 5.23▼ 5.22▼ 5.18▼ 5.59▼
MA100 5.13▼ 5.21▼ 5.14▼ 5.08▲ 5.54▼
MA200 5.18▼ 5.13▼ 5.16▼ 5.66▼ 4.82▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ 0.006▲ -0.006▼ 0.011▲ 0.036▲
RSI 49.404▼ 44.718▼ 44.719▼ 48.348▼ 46.853▼
STOCH 38.333     44.206     46.895     62.786     43.386    
WILL %R -54.545     -63.333     -66.667     -68.657     -44.664    
CCI -25.511     -26.923     -22.784     -23.886     51.164    
Latest Filters Detected On ABEO
RSI $ABEO RSI(14) Crossed Below 50 Set Alert
MA $ABEO Price Crossed Below MA(50) Set Alert
MA $ABEO Price Crossed Below MA(26) Set Alert
MA $ABEO Price Crossed Below MA(13) Set Alert
CDL $ABEO Doji Star Candlestick Pattern Detected Set Alert
CDL $ABEO Doji Candlestick Pattern Detected Set Alert
Abeona Therapeutics Inc News
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday, December 30, 2025 11:30 PM
CLEVELAND, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new executive and non-executive employees who joined the Company.
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
Thursday, December 11, 2025 04:30 AM
CLEVELAND, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in Galveston, Texas, as the newest ...
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
Monday, December 08, 2025 04:30 AM
CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the first commercial patient treatment with FDA-approved ZEVASKYN (prademagene zamikeracel), a ...
ABEO historical stock data
date open high low close volume
27/02/26 5.115 5.17 5.065 5.12 501,529
26/02/26 5.30 5.31 5.035 5.20 905,424
25/02/26 5.43 5.58 5.25 5.30 1,095,000
24/02/26 5.20 5.43 5.165 5.40 1,747,566
23/02/26 5.25 5.33 5.131 5.18 603,899
20/02/26 5.23 5.285 5.09 5.26 714,246
19/02/26 5.10 5.32 5.05 5.29 1,738,400
18/02/26 5.04 5.12 4.99 5.12 401,853
17/02/26 4.99 5.0708 4.91 5.04 647,742
13/02/26 5.01 5.09 4.975 5.01 435,859
Quote Details
52wk Low:3.933
52wk High:7.54
Vol:12.21K
Avg Vol(3m):23.1M
1Y Chng:-3.40%
1M Chng:-6.06%
Add to Watch List
More Information
Index US Composite
Market Cap. 287.21M